ZEPP · Zepp Health Corp · Metrics
$2.30
-0.04 (-1.71%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$35.20M
Shares
14.66M
Volume · Oct 29
35.27K
Avg daily vol (3M)
46.59K
ZEPP metrics
72 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$2.34
Market cap
$35.20M
Price action
20 metricsPrice change (1W)
-13.0%
Price change (30D)
-38.0%
Price change (3M)
-48.1%
Price change (6M)
-85.7%
Price change (YTD)
-91.1%
Price change (1Y)
-94.8%
Trailing year
Price change (5Y)
—
52-week high
$46.00
52-week low
$2.41
Change from 52-week high
-94.8%
Change from 52-week low
+0.0%
Annualized volatility
102.2%
Annualized volatility (3M)
59.2%
Beta
2.2
RSI (14D)
13.4
Price vs SMA 50
-41.9%
Price vs SMA 200
-77.0%
Avg volume (3M)
45,441
Relative volume
1.8
Average dollar volume
$193,683
Company
3 metricsSector
Technology
Industry
Consumer Electronics
Shares outstanding
14.66M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.8×
reciprocal yield 130.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 768.2%
P / book
0.2
reciprocal yield 514.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-121.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-09-02
Profitability
9 metricsGross margin
38.6%
Operating margin
-12.6%
Trailing 12 months
Net margin
-15.8%
Gross profit (TTM)
$106.50M
Operating profit (TTM)
−$34.75M
Net income (TTM)
−$43.56M
Trailing 12 months
Diluted EPS (TTM)
$-2.72
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+6.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$276.03M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.1%
Year over year · fewer shares
Revenue CAGR (3Y)
-25.0%
Revenue CAGR (5Y)
-23.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-23.6%
Return on assets
-7.8%
Debt / equity
1.3
Current ratio
0.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$175.25M
Latest balance sheet
Cash & equivalents
$69.66M
Total assets
$559.67M
Total debt
$244.91M
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
−$46.46M
SG&A (TTM)
−$94.79M
Stock compensation (TTM)
—
R&D / revenue
-16.8%
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
28
13F filer change QoQ
-7
Institutional ownership
15.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-39.3%
Holder tenure
9.5
Price vs estimated holder cost
-81.0%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.2%
Short interest
3 metricsShort interest
2.3%
Latest settlement · 16.5 days to cover
Days to cover
16.5d
Short-squeeze score
59 / 100
Insider activity
2 metricsNet insider buying (90D)
−$42,110
Insider-sentiment score
43 / 100
Risk flags
1 metricsGoing concern
—